Role of p53 Serine 46 in p53 Target Gene Regulation
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 plays a crucial role in cellular growth control inducing a plethora of different response pathways. The molecular mechanisms that discriminate between the distinct p53-responses have remained largely elusive. Here, we have analyzed the p53-regulated pathways induced by Actinomycin D and Etoposide treatment resulting in more growth arrested versus apoptotic cells respectively. We found that the genome-wide p53 DNA-binding patterns are almost identical upon both treatments notwithstanding transcriptional differences that we observed in global transcriptome analysis. To assess the role of post-translational modifications in target gene choice and activation we investigated the genome-wide level of phosphorylation of Serine 46 of p53 bound to DNA (p53-pS46) and of Serine 15 (p53-pS15). Interestingly, the extent of S46 phosphorylation of p53 bound to DNA is considerably higher in cells directed towards apoptosis while the degree of phosphorylation at S15 remains highly similar. Moreover, our data suggest that following different chemotherapeutical treatments, the amount of chromatin-associated p53 phosphorylated at S46 but not at pS15 is higher on certain apoptosis related target genes. Our data provide evidence that cell fate decisions are not made primarily on the level of general p53 DNA-binding and that post-translationally modified p53 can have distinct DNA-binding characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 2×
“Data availability The data have been deposited in NCBI’s Gene Expression Omnibus [52] and are accessible through GEO Series accession number GSE22186 (http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE22186).”
MethodVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“. In response to a cellular stress signal p53 gets stabilized and regulates the expression of target genes involved in growth arrest, apoptosis and other responses”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 2×
“Several lines of evidence lead to the threshold model in which the amount of p53 protein present in a cell determines if cells go into apoptosis [3].”
BackgroundA microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270 · cited 2×
“A series of post-translational modifications of p53 is involved in mediating transactivation upon stress by stabilizing and activating p53, such as phosphorylation, acetylation, methylation, neddylation, sumoylation and ubiquitination [6,10,11].”
BackgroundA Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141
DNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · cited 1×
“While some post-translational modifications (PTMs) are thought to be necessary for p53 activity in general such as p53 phosphorylation at Serine 15 [32], phosphorylation of Serine 46 has been proposed to be involved in the activation of certain apoptotic target genes, such as p53 apoptosis inducing protein 1 (p53AIP1)…”
BackgroundReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
Characterization of genome-wide p53-binding sites upon stress response
Smeenk, L., van Heeringen, S. J., Koeppel, M., van Driel, M. A., Bartels, S. J. J., Akkers, R. C., Denissov, S., Stunnenberg, H. G., & Lohrum, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn232 · Cited by 211 · cited 1×
“To characterize sequences underlying the binding sites, we analyzed them with the p53scan algorithm [23] and found that the vast majority of the identified p53-binding sites (86% and 88% respectively) contain a p53 consensus motif irrespective of the treatment.”
MethodSelf-citationThe p53 response: Emerging levels of co-factor complexity
Coutts, A. S., & La Thangue, N. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.150 · Cited by 72 · cited 1×
“The p53 activity is tightly regulated in the cell by co-factors”
Background
Research works printed but not linked: 41
- SP Hussain, 1999, p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer., Mutat Res, 428, 23, 10.1016/S1383-5742(99)00028-9 · DOI · Paper page
- J Espinosa, 2008, Mechanisms of regulatory diversity within the p53 transcriptional network., Oncogene, 27, 4013, 10.1038/onc.2008.37 · DOI
- A Sullivan, 2007, ASPP: a new family of oncogenes and tumour suppressor genes., Br J Cancer, 96, 196, 10.1038/sj.bjc.6603525 · DOI · Paper page
- S Das, 2007, Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation., Cell, 130, 624, 10.1016/j.cell.2007.06.013 · DOI · Paper page
- T Tanaka, 2007, hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes., Cell, 130, 638, 10.1016/j.cell.2007.08.001 · DOI · Paper page
- A Olsson, 2007, How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?, Cell Death Differ, 14, 1561, 10.1038/sj.cdd.4402196 · DOI · Paper page
- CL Brooks, 2003, Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation., Curr Opin Cell Biol, 15, 164, 10.1016/S0955-0674(03)00003-6 · DOI · Paper page
- KK Khanna, 1998, ATM associates with and phosphorylates p53: mapping the region of interaction., Nat Genet, 20, 398, 10.1038/3882 · DOI · Paper page
- K Oda, 2000, p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53., Cell, 102, 849, 10.1016/S0092-8674(00)00073-8 · DOI · Paper page
- TG Hofmann, 2002, Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2., Nat Cell Biol, 4, 1, 10.1038/ncb715 · DOI · Paper page
- G D'orazi, 2002, Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis., Nat Cell Biol, 4, 11, 10.1038/ncb714 · DOI · Paper page
- N Taira, 2007, DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage., Mol Cell, 25, 725, 10.1016/j.molcel.2007.02.007 · DOI · Paper page
- M Kodama, 2010, Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences., Molecular and Cellular Biology, 30, 1620, 10.1128/MCB.00810-09 · DOI
- K Yoshida, 2006, Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage., J Biol Chem, 281, 5734, 10.1074/jbc.M512074200 · DOI · Paper page
- R Okoshi, 2008, Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress., J Biol Chem, 283, 3979, 10.1074/jbc.M705232200 · DOI · Paper page
- JL Perfettini, 2005, Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope., J Exp Med, 201, 279, 10.1084/jem.20041502 · DOI · Paper page
- Y Zhang, 2008, Model-based analysis of ChIP-Seq (MACS)., Genome Biol, 9, R137, 10.1186/gb-2008-9-9-r137 · DOI · Paper page
- KD Pruitt, 2007, NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins., Nucleic Acids Res, 35, D61, 10.1093/nar/gkl842 · DOI · Paper page
- daW Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources., Nat Protoc, 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- TR Hupp, 1992, Regulation of the specific DNA binding function of p53., Cell, 71, 875, 10.1016/0092-8674(92)90562-Q · DOI · Paper page
- KH Vousden, 2000, p53: death star., Cell, 103, 691, 10.1016/S0092-8674(00)00171-9 · DOI · Paper page
- L Vrba, 2008, p53 induces distinct epigenetic states at its direct target promoters., BMC Genomics, 9, 486, 10.1186/1471-2164-9-486 · DOI · Paper page
- MD Kaeser, 2002, From the Cover: Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity invivo., PNAS, 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
- H Shaked, 2008, Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines., Cancer Research, 68, 9671, 10.1158/0008-5472.CAN-08-0865 · DOI · Paper page
- LD Mayo, 2005, Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified., J Biol Chem, 280, 25953, 10.1074/jbc.M503026200 · DOI · Paper page
- DV Bulavin, 1999, Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation., EMBO J, 18, 6845, 10.1093/emboj/18.23.6845 · DOI · Paper page
- A Shmueli, 2007, Mdm2: p53's lifesaver?, Mol Cell, 25, 794, 10.1016/j.molcel.2007.03.006 · DOI
- C Rinaldo, 2007, MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis., Mol Cell, 25, 739, 10.1016/j.molcel.2007.02.008 · DOI · Paper page
- Y Tang, 2006, Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis., Mol Cell, 24, 827, 10.1016/j.molcel.2006.11.021 · DOI · Paper page
- L Smeenk, 2010, Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review)., Int J Oncol, 37, 1061
- C Dai, 2010, p53 post-translational modification: deregulated in tumorigenesis., Trends Mol Med, 16, 528, 10.1016/j.molmed.2010.09.002 · DOI · Paper page
- P Zacchi, 2002, The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults., Nature, 419, 853, 10.1038/nature01120 · DOI · Paper page
- CD Braastad, 2003, Constitutive DNase I hypersensitivity of p53-regulated promoters., J Biol Chem, 278, 8261, 10.1074/jbc.M204256200 · DOI
- CJ Braun, 2008, p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest., Cancer Research, 68, 10094, 10.1158/0008-5472.CAN-08-1569 · DOI · Paper page
- SA Georges, 2009, Cell cycle arrest or apoptosis by p53: are microRNAs-192/215 and -34 making the decision?, Cell Cycle, 8, 680, 10.4161/cc.8.5.8076 · DOI
- H Hermeking, 2007, p53 enters the microRNA world., Cancer Cell, 12, 414, 10.1016/j.ccr.2007.10.028 · DOI · Paper page
- MA Lohrum, 2001, C-terminal ubiquitination of p53 contributes to nuclear export., Molecular and Cellular Biology, 21, 8521, 10.1128/MCB.21.24.8521-8532.2001 · DOI · Paper page
- S Denissov, 2007, Identification of novel functional TBP-binding sites and general factor repertoires., Embo J, 26, 944, 10.1038/sj.emboj.7601550 · DOI
- RA Irizarry, 2003, Summaries of Affymetrix GeneChip probe level data., Nucleic Acids Res, 31, e15, 10.1093/nar/gng015 · DOI · Paper page
- MJ de Hoon, 2004, Open source clustering software., Bioinformatics, 20, 1453, 10.1093/bioinformatics/bth078 · DOI · Paper page
- AJ Saldanha, 2004, Java Treeview–extensible visualization of microarray data., Bioinformatics, 20, 3246, 10.1093/bioinformatics/bth349 · DOI · Paper page
Cited by
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Kenzelmann Broz, D., Spano Mello, S., Bieging, K. T., Jiang, D., Dusek, R. L., Brady, C. A., Sidow, A., & Attardi, L. D. (2013) · Genes & Development · doi:10.1101/gad.212282.112 · Cited by 443
“%) or within introns (41.7%), consistent with previous studies showing that p53-binding sites are commonly found in introns of target genes (Wei et al. 2006; Smeenk et al. 2011).”
BackgroundMethodResultInfluentialLong non-coding RNAs in Huntington's disease neurodegeneration
Johnson, R. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.006 · Cited by 398
Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330
A benchmark for chromatin binding measurements in live cells
Mazza, D., Abernathy, A., Golob, N., Morisaki, T., & McNally, J. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks701 · Cited by 303
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Abuetabh, Y., Wu, H. H., Chai, C., Al Yousef, H., Persad, S., Sergi, C. M., & Leng, R. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00863-4 · Cited by 272
Deconstructing p53 transcriptional networks in tumor suppression
Bieging, K. T., & Attardi, L. D. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.006 · Cited by 194
Menendez, D., Nguyen, T.-A., Freudenberg, J. M., Mathew, V. J., Anderson, C. W., Jothi, R., & Resnick, M. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt504 · Cited by 154
“(12) using 24 h treatments with Actinomycin D or Etoposide, we found 270 common p53 binding sites that are near a TSS for all treatments (DMSO, DXR, Nutlin, Etoposide and Actinomycin D; Supplementary Data Set 6).”
BackgroundMethodInfluentialThe transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Zeron-Medina, J., Wang, X., Repapi, E., Campbell, M. R., Su, D., Castro-Giner, F., Davies, B., Peterse, E. F. P., Sacilotto, N., Walker, G. J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.017 · Cited by 118
“of almost all known transcripts, many more important p53 target genes are currently being defined (Bandele et al., 2011; Botcheva et al., 2011; Nikulenkov et al., 2012; Smeenk et al., 2011; Wei et al., 2006).”
Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., & Stiewe, T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003726 · Cited by 87
Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic
Verfaillie, A., Svetlichnyy, D., Imrichova, H., Davie, K., Fiers, M., Kalender Atak, Z., Hulselmans, G., Christiaens, V., & Aerts, S. (2016) · Genome Research · doi:10.1101/gr.204149.116 · Cited by 82
Bourgeois, B., Spreitzer, E., Platero-Rochart, D., Paar, M., Zhou, Q., Usluer, S., de Keizer, P. L. J., Burgering, B. M. T., Sánchez-Murcia, P. A., & Madl, T. (2025) · Nature Communications · doi:10.1038/s41467-025-60844-9 · Cited by 23
Romero-Benavides, J. C., Bailon-Moscoso, N., Parra-Delgado, H., Ramirez, M. I., Villacis, J., Cabrera, H., Gonzalez-Arevalo, G., Cueva, R., Zentella-Dehesa, A., Ratovitski, E. A., et al. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2106-4 · Cited by 17
Interleukin-1α associates with the tumor suppressor p53 following DNA damage
Novak, J., Zamostna, B., Vopalensky, V., Buryskova, M., Burysek, L., Doleckova, D., & Pospisek, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63779-x · Cited by 3
Metadata
- Authors
- Smeenk, L., van Heeringen, S. J., Koeppel, M., Gilbert, B., Janssen-Megens, E., Stunnenberg, H. G., & Lohrum, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-04
- Volume
- 6
- Issue
- 3
- Pages
- e17574
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2098276373
- Cited by
- 169
- References
- 10
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.